Research ArticleArticle
Establishment of an Isogenic Human Colon Tumor Model forNQO1 Gene Expression: Application to Investigate the Role of DT-Diaphorase in Bioreductive Drug Activation In Vitro and In Vivo
Swee Y. Sharp, Lloyd R. Kelland, Melanie R. Valenti, Lisa A. Brunton, Steve Hobbs and Paul Workman
Molecular Pharmacology November 2000, 58 (5) 1146-1155; DOI: https://doi.org/10.1124/mol.58.5.1146
Swee Y. Sharp
CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
Lloyd R. Kelland
CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
Melanie R. Valenti
CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
Lisa A. Brunton
CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
Steve Hobbs
CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
Paul Workman
CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Establishment of an Isogenic Human Colon Tumor Model forNQO1 Gene Expression: Application to Investigate the Role of DT-Diaphorase in Bioreductive Drug Activation In Vitro and In Vivo
Swee Y. Sharp, Lloyd R. Kelland, Melanie R. Valenti, Lisa A. Brunton, Steve Hobbs and Paul Workman
Molecular Pharmacology November 1, 2000, 58 (5) 1146-1155; DOI: https://doi.org/10.1124/mol.58.5.1146
Research ArticleArticle
Establishment of an Isogenic Human Colon Tumor Model forNQO1 Gene Expression: Application to Investigate the Role of DT-Diaphorase in Bioreductive Drug Activation In Vitro and In Vivo
Swee Y. Sharp, Lloyd R. Kelland, Melanie R. Valenti, Lisa A. Brunton, Steve Hobbs and Paul Workman
Molecular Pharmacology November 1, 2000, 58 (5) 1146-1155; DOI: https://doi.org/10.1124/mol.58.5.1146